Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 21 studies | 32% ± 12% | |
smooth muscle cell | 13 studies | 25% ± 9% | |
astrocyte | 9 studies | 31% ± 10% | |
connective tissue cell | 7 studies | 26% ± 12% | |
myofibroblast cell | 6 studies | 28% ± 8% | |
pericyte | 6 studies | 22% ± 5% | |
memory B cell | 6 studies | 18% ± 2% | |
oligodendrocyte precursor cell | 4 studies | 26% ± 8% | |
plasma cell | 3 studies | 22% ± 4% | |
microglial cell | 3 studies | 23% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 100% | 2509.81 | 180 / 180 | 99% | 23.61 | 425 / 430 |
brain | 95% | 1283.88 | 2520 / 2642 | 99% | 25.73 | 700 / 705 |
thymus | 98% | 1648.33 | 641 / 653 | 96% | 21.21 | 579 / 605 |
breast | 98% | 2144.54 | 451 / 459 | 93% | 13.95 | 1044 / 1118 |
prostate | 99% | 2121.38 | 242 / 245 | 93% | 10.75 | 466 / 502 |
bladder | 100% | 3035.10 | 21 / 21 | 74% | 6.42 | 371 / 504 |
lung | 89% | 1021.35 | 516 / 578 | 77% | 7.55 | 895 / 1155 |
esophagus | 84% | 2317.48 | 1207 / 1445 | 79% | 9.18 | 145 / 183 |
uterus | 99% | 2904.01 | 169 / 170 | 63% | 6.92 | 290 / 459 |
adrenal gland | 93% | 986.29 | 239 / 258 | 65% | 3.86 | 149 / 230 |
intestine | 89% | 2310.19 | 861 / 966 | 56% | 4.87 | 295 / 527 |
kidney | 42% | 333.64 | 37 / 89 | 86% | 14.56 | 778 / 901 |
stomach | 53% | 973.34 | 189 / 359 | 66% | 6.56 | 188 / 286 |
skin | 58% | 490.86 | 1048 / 1809 | 57% | 5.59 | 271 / 472 |
pancreas | 14% | 91.18 | 45 / 328 | 95% | 14.13 | 169 / 178 |
blood vessel | 100% | 4580.01 | 1335 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 3388.71 | 799 / 803 | 0% | 0 | 0 / 0 |
adipose | 99% | 2031.43 | 1191 / 1204 | 0% | 0 | 0 / 0 |
heart | 96% | 2521.51 | 828 / 861 | 0% | 0 | 0 / 0 |
spleen | 71% | 500.07 | 172 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 62% | 4.63 | 28 / 45 |
eye | 0% | 0 | 0 / 0 | 50% | 3.59 | 40 / 80 |
lymph node | 0% | 0 | 0 / 0 | 14% | 0.53 | 4 / 29 |
liver | 0% | 0 | 0 / 226 | 12% | 0.88 | 48 / 406 |
peripheral blood | 2% | 9.93 | 16 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007155 | Biological process | cell adhesion |
GO_0006936 | Biological process | muscle contraction |
GO_0042383 | Cellular component | sarcolemma |
GO_0016010 | Cellular component | dystrophin-associated glycoprotein complex |
GO_0005886 | Cellular component | plasma membrane |
GO_0045211 | Cellular component | postsynaptic membrane |
GO_0030133 | Cellular component | transport vesicle |
Gene name | SSPN |
Protein name | Sarcospan Sarcospan (K-ras oncogene-associated protein) (Kirsten-ras-associated protein) |
Synonyms | KRAG |
Description | FUNCTION: Component of the dystrophin-glycoprotein complex (DGC), a complex that spans the muscle plasma membrane and forms a link between the F-actin cytoskeleton and the extracellular matrix. Preferentially associates with the sarcoglycan subcomplex of the DGC. |
Accessions | ENST00000538142.5 F5H0K2 ENST00000535504.1 ENST00000422622.3 [Q14714-3] F5H381 Q14714 ENST00000540266.5 [Q14714-3] ENST00000242729.7 [Q14714-1] |